Zidovudine, lamivudine and dolutegravir (AXD) Relative to Tenofovir, lamivudine and dolutegravir (TXD) In Second Line Antiretroviral Therapy (ARTIST) Trial: a randomised controlled trial

Principal investigator

Location

South Africa
Topic

HIV/AIDS
Methodology

Randomised controlled trial (RCT)
Reference

OCB1901
Views

738
Downloaded

0

Purpose of study

As the HIV epidemic matures and more patients are initiated on antiretroviral treatment, focus is on ensuring that those on antiretroviral therapy are virologically suppressed. The strategy to support virological suppression on second-line include...

Study status

Concept
Protocol & ERB
Implementation
Completion
Archived

Study timeline

Documents

1179-erb-documentation-2023-07-19.pdf 49.7 KB
1179-erb-documentation-2023-04-17.pdf 121 KB
1179-protocol-2023-04-17.doc 445 KB

Publications

AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial

Zhao, Ying "–" F1000 Research Ltd "(2021)"

Previous study

Next study